Faeces screening | |
Calprotectine | |
Bacteria | |
Clostridium difficile | Yersinia enterocolitica |
Helicobacter pylori | Plesiomonas shigelloides |
Salmonella sp | Pathogenic Campylobacter sp |
Shigella sp | Shiga toxin-producing Escherichia coli |
Antibiotic-resistant bacteria | |
Vancomycin-resistant Enterococcus | Multidrug-resistant Gram-negative (MRGN) 3 |
Carbapenem-resistant Enterobacteriaceae | MRGN 4 |
Methicillin-resistant Staphylococcus aureus | Extended spectrum beta-lactamase-producing Enterobactereacceae |
Viruses | |
Hepatitis E | Rotavirus |
Norovirus type I and II | Enterovirus |
Astrovirus | Adenovirus non-41/41 |
Sapovirus | Parechovirus |
Adenovirus type 40/41 | COVID-19 |
Parasites | |
Giardia lamblia | Microsporidium sp |
Cryptosporidium sp | Blastocystis hominis* |
Entamoeba histolytica | Isospora sp |
Dientamoeba fragilis | Cyclospora |
Non-pathogenic parasites† | |
Entamoeba gingivalis | Endolimax nana |
Entamoeba hartmanni | Iodamoeba bütschlii |
Entamoeba coli | Entamoeba dispar |
Entamoeba polecki | Entamoeba moshkovskii |
Other | |
Parasitic worm eggs | Protozoan cysts and oocysts |
Larvae | |
Serum screening | |
Haematology | |
Complete blood count | Gamma-glutamyl transferase |
Bilirubine | Alkaline phosphatase |
C-reactive protein | Kreatinine |
Aspartate aminotransferase | Ureum |
Alanine aminotransferase | Estimated glomerular filtration rate |
Bacteria | |
Lues | |
Viruses | |
Hepatitis A | Cytomegalovirus |
Hepatitis B | Epstein-Barr virus |
Hepatitis C | Human T-lymphotropic virus |
HIV | |
Parasites | |
Strongyloides |
*Exclusion of donor only if microscopically ‘much’ or ‘very much’ blastocystis are seen.
†Presence of only one non-pathogenic parasite is acceptable.